Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network James D. Chalmers, Felix C. Ringshausen, Bridget Harris, J. Stuart Elborn, Annette Posthumus, Charles S. Haworth, Nicola Pilkington, Eva Polverino, Thomas Ruddy, Stefano Aliberti, Pieter C. Goeminne, Craig Winstanley, Anthony De Soyza
Source: Eur Respir J, 51 (1) 1701937; 10.1183/13993003.01937-2017 Disease area: Respiratory infectionsRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
James D. Chalmers, Felix C. Ringshausen, Bridget Harris, J. Stuart Elborn, Annette Posthumus, Charles S. Haworth, Nicola Pilkington, Eva Polverino, Thomas Ruddy, Stefano Aliberti, Pieter C. Goeminne, Craig Winstanley, Anthony De Soyza. Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network. Eur Respir J, 51 (1) 1701937; 10.1183/13993003.01937-2017
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Research priorities in bronchiectasis: A consensus from the European multicentre bronchiectasis audit and research collaboration (EMBARC) study group Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015
Longitudinal data-driven definition of clinical asthma phenotypes in the pediatric arm of the All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL) Source: Virtual Congress 2020 – Hot topics in paediatric asthma Year: 2020
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation Source: Eur Respir J, 53 (1) 1802089; 10.1183/13993003.02089-2018 Year: 2019
Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020
The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis Source: Breathe, 13 (3) e65; 10.1183/20734735.005517 Year: 2017
European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Source: Eur Respir J 2002; 19: 765-775 Year: 2002
Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC) Source: International Congress 2016 – Clinical update on bronchiectasis Year: 2016
Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017
Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015
Difficult to manage COPD Exacerbations: Risk factors (DIMECO Study). Turkish Thoracic Society COPD Assembly. Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases Year: 2020
Asthma control index in European countries: The LIAISON (InternationaL cross-sectIonAl and longitudinal assessment on aSthma cONtrol) study cross-sectional results Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014
Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease Source: Eur Respir J 2016; 47:1345-1347 Year: 2016
Evaluation of the Integrated Tuberculosis Research Programme (PII TB) by SEPAR (Spanish Respiratory Society) Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019
The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research Source: Eur Respir J, 52 (5) 1801671; 10.1183/13993003.01671-2018 Year: 2018
The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP) Source: Eur Respir J, 49 (5) 1602295; 10.1183/13993003.02295-2016 Year: 2017
Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study Source: Eur Respir J, 56 (1) 1902004; 10.1183/13993003.02004-2019 Year: 2020
Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry Source: Breathe, 14 (2) 93; 10.1183/20734735.002018 Year: 2018
Evaluation of COPD Patient’s Relatives Assessment of Disease Awarness, Load of Care Giving and Loss of Workforce: Turkish Thoracic Society COPD Working Group. Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Source: Eur Respir J 2012; 39: 619-625 Year: 2012
The European Network for ICU-Related Respiratory Infections (ENIRRIs) ERS Clinical Research Collaboration Source: Eur Respir J, 53 (1) 1801972; 10.1183/13993003.01972-2018 Year: 2019